Your browser doesn't support javascript.
loading
CpG preconditioning regulates miRNA expression that modulates genomic reprogramming associated with neuroprotection against ischemic injury.
Vartanian, Keri B; Mitchell, Hugh D; Stevens, Susan L; Conrad, Valerie K; McDermott, Jason E; Stenzel-Poore, Mary P.
Afiliação
  • Vartanian KB; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, Oregon, USA.
  • Mitchell HD; Pacific Northwest National Laboratory, Richland, Washington, USA.
  • Stevens SL; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, Oregon, USA.
  • Conrad VK; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, Oregon, USA.
  • McDermott JE; Pacific Northwest National Laboratory, Richland, Washington, USA.
  • Stenzel-Poore MP; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, Oregon, USA.
J Cereb Blood Flow Metab ; 35(2): 257-66, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25388675
ABSTRACT
Cytosine-phosphate-guanine (CpG) preconditioning reprograms the genomic response to stroke to protect the brain against ischemic injury. The mechanisms underlying genomic reprogramming are incompletely understood. MicroRNAs (miRNAs) regulate gene expression; however, their role in modulating gene responses produced by CpG preconditioning is unknown. We evaluated brain miRNA expression in response to CpG preconditioning before and after stroke using microarray. Importantly, we have data from previous gene microarrays under the same conditions, which allowed integration of miRNA and gene expression data to specifically identify regulated miRNA gene targets. CpG preconditioning did not significantly alter miRNA expression before stroke, indicating that miRNA regulation is not critical for the initiation of preconditioning-induced neuroprotection. However, after stroke, differentially regulated miRNAs between CpG- and saline-treated animals associated with the upregulation of several neuroprotective genes, implicating these miRNAs in genomic reprogramming that increases neuroprotection. Statistical analysis revealed that the miRNA targets were enriched in the gene population regulated in the setting of stroke, implying that miRNAs likely orchestrate this gene expression. These data suggest that miRNAs regulate endogenous responses to stroke and that manipulation of these miRNAs may have the potential to acutely activate novel neuroprotective processes that reduce damage.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligodesoxirribonucleotídeos / Isquemia Encefálica / Regulação da Expressão Gênica / Fármacos Neuroprotetores / Acidente Vascular Cerebral / MicroRNAs Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligodesoxirribonucleotídeos / Isquemia Encefálica / Regulação da Expressão Gênica / Fármacos Neuroprotetores / Acidente Vascular Cerebral / MicroRNAs Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article